Stockreport

Why Omeros (OMER) Is Up 74.0% After First-In-Class TA-TMA Drug Wins FDA Approval [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children aged two and older, with a U.S. launch planned for January 2026 and an EMA dec [Read more]